Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 721,654 |
|
|||||
| News | - | ||||||
| Day High | 1.798 | Low High |
|||||
| Day Low | 1.59 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sensei Biotherapeutics Inc | SNSE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.11 | 6.67% | 1.76 | 18:47:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.76 | 1.59 | 1.798 | 1.79 | 1.65 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,233 | 721,654 | US$ 1.69 | US$ 1,216,011 | - | 0.51 - 1.92 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:56:46 | 50 | US$ 1.76 | USD |
Sensei Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 44.38M | 25.07M | - | 0 | -34.1M | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sensei Biotherapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/05/2024 | 15:44 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/28/2024 | 06:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 17:37 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/16/2024 | 17:28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/16/2024 | 17:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/08/2024 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 07:14 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/07/2023 | 15:40 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/07/2023 | 06:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/07/2023 | 06:30 | GlobeNewswire Inc. | Sensei Biotherapeutics Reports Third Quarter 2023 Financial.. |
| 11/06/2023 | 05:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/03/2023 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNSE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.04 | 1.92 | 0.9712 | 1.59 | 994,733 | 0.72 | 69.23% |
| 1 Month | 0.97 | 1.92 | 0.9101 | 1.47 | 321,598 | 0.79 | 81.44% |
| 3 Months | 0.79 | 1.92 | 0.74 | 1.31 | 158,354 | 0.97 | 122.78% |
| 6 Months | 0.78 | 1.92 | 0.5524 | 1.13 | 107,088 | 0.98 | 125.64% |
| 1 Year | 1.55 | 1.92 | 0.51 | 1.11 | 66,208 | 0.21 | 13.55% |
| 3 Years | 13.25 | 15.12 | 0.51 | 4.24 | 81,700 | -11.49 | -86.72% |
| 5 Years | 24.70 | 26.38 | 0.51 | 6.61 | 91,733 | -22.94 | -92.87% |
Sensei Biotherapeutics Description
| Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. |
